Trelegy Ellipta 00173-0887
Generic: Fluticasone Furoate, Umeclidinium Bromide And Vilanterol Trifenatate
Product NDC
00173-0887- Manufacturer
- Glaxosmithkline Llc
- Dosage Form
- Powder
- Route
- Respiratory (inhalation)
- Product Type
- Human Prescription Drug
- Marketing Start
- September 18, 2017
- Listing Expires
- December 31, 2026
- Application
- NDA209482
Need to source Trelegy Ellipta? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Fluticasone Furoate | 100 ug/1 |
| Umeclidinium Bromide | 62.5 ug/1 |
| Vilanterol Trifenatate | 25 ug/1 |
Drug Class
Adrenergic beta2-Agonists [MoA]Anticholinergic [EPC]Cholinergic Antagonists [MoA]
Packaging Options(3)
1 TRAY in 1 CARTON (0173-0887-10) / 1 INHALER in 1 TRAY / 30 POWDER in 1 INHALER
1 TRAY in 1 CARTON (0173-0887-14) / 1 INHALER in 1 TRAY / 14 POWDER in 1 INHALER
1 TRAY in 1 CARTON (0173-0887-61) / 1 INHALER in 1 TRAY / 14 POWDER in 1 INHALER
Related Products
All Fluticasone Furoate, Umeclidinium Bromide And Vilanterol Trifenatate NDC codes →External Resources